Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs (950130) Financial Statements
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs Financial Overview
Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs's market cap is currently $67.67B. The company's EPS TTM is $-621.17; its P/E ratio is -645.45; and it has a dividend yield of 7.05%. Access Bio, Inc. Shs Korean Deposit Receipt Repr. 1 shs has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 112.46B | $ 348.64B | $ 1.03T | $ 505.11B | $ 121.80B |
| Gross Profit | $ 53.63B | $ 170.26B | $ 819.77B | $ 396.39B | $ 90.75B |
| Operating Income | $ -4.23B | $ 21.59B | $ 469.20B | $ 260.12B | $ 68.71B |
| EBITDA | $ 23.40B | $ 13.79B | $ 480.76B | $ 266.17B | $ 67.76B |
| Net Income | $ -347.58M | $ -3.17B | $ 346.67B | $ 189.69B | $ 48.27B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 454.85B | $ 346.98B | $ 498.71B | $ 200.33B | $ 50.35B |
| Total Assets | $ 740.85B | $ 691.14B | $ 885.48B | $ 442.01B | $ 170.18B |
| Total Debt | $ 66.00B | $ 73.14B | $ 75.42B | $ 70.08B | $ 47.27B |
| Net Debt | $ -276.25B | $ -204.47B | $ -397.78B | $ -129.00B | $ -1.94B |
| Total Liabilities | $ 88.45B | $ 104.00B | $ 259.38B | $ 151.96B | $ 83.50B |
| Stockholders' Equity | $ 650.15B | $ 584.16B | $ 618.11B | $ 286.59B | $ 83.72B |
| Cash Flow | |||||
| Free Cash Flow | $ 17.85B | $ -122.56B | $ 350.29B | $ 129.37B | $ 26.05B |
| Operating Cash Flow | $ 19.90B | $ -103.88B | $ 369.20B | $ 163.48B | $ 36.72B |
| Investing Cash Flow | $ 17.47B | $ -46.49B | $ -37.75B | $ -34.93B | $ -8.81B |
| Financing Cash Flow | $ -7.56B | $ -53.99B | $ -67.41B | $ 18.01B | $ 15.33B |
Currency in KRW